↓ Skip to main content

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
Published in
Journal for Immunotherapy of Cancer, August 2014
DOI 10.1186/s40425-014-0030-4
Pubmed ID
Authors

Hirokazu Matsushita, Yutaka Enomoto, Haruki Kume, Tohru Nakagawa, Hiroshi Fukuhara, Motofumi Suzuki, Tetsuya Fujimura, Yukio Homma, Kazuhiro Kakimi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 20%
Student > Bachelor 4 11%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Professor 2 6%
Other 8 23%
Unknown 9 26%
Readers by discipline Count As %
Medicine and Dentistry 13 37%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 3 9%
Agricultural and Biological Sciences 2 6%
Unspecified 1 3%
Other 3 9%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2015.
All research outputs
#14,600,874
of 25,374,917 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,346
of 3,421 outputs
Outputs of similar age
#117,425
of 247,171 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#6
of 10 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,171 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.